Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia

This publication has 26 references indexed in Scilit:

• Drug management of hypercholesterolemia
  American Heart Journal, 1979
• Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
  Circulation, 1979
• Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality
  Journal of Chronic Diseases, 1978
• Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia
  Archives of internal medicine (1960), 1977
• A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
  Published by Wiley ,1977
• Clofibrate and niacin in coronary heart disease
  JAMA, 1975
• Long-term Changes of Serum Cholesterol with Cholesterol-altering Drugs in Patients with Coronary Heart Disease
  Circulation, 1974
• Probucol in the long-term treatment of hypercholesterolaemia
  Current Medical Research and Opinion, 1973
• Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia
  JAMA, 1972
• Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemia
  Atherosclerosis, 1972